Search research articles
Contact Us
Filters
Showing results (331-340 of 602) with videos related to
Page
of 61
Sort By:
Parkinsonism & Related Disorders
|
December 22, 2019
Midbrain hyperechogenicity, hyposmia, mild parkinsonian signs and risk for incident Parkinson's disease over 10 years: A prospective population-based study
Philipp Mahlknecht, Heike Stockner, Kathrin Marini, et al.
Annals of Neurology
|
July 23, 2005
Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome
Christoph Schmidauer, Martin Sojer, Klaus Seppi, et al.
Pharmacoeconomics - Open
|
October 31, 2025
Cost-Effectiveness Modelling of Multiple System Atrophy for Early Health Technology Assessment
Tobias Sydendal Grand, Shijie Ren, Praveen Thokala, et al.
Neuro-Degenerative Diseases
|
May 22, 2013
Substantia nigra hyperechogenicity as a marker for Parkinson's disease: a population-based study
Philipp Mahlknecht, Klaus Seppi, Heike Stockner, et al.
Brain Sciences
|
May 28, 2022
Eye Tracking in Patients with Parkinson's Disease Treated with Nabilone-Results of a Phase II, Placebo-Controlled, Double-Blind, Parallel-Group Pilot Study
Philipp Ellmerer, Marina Peball, Federico Carbone, et al.
Parkinsonism & Related Disorders
|
January 30, 2025
Long-term, continuous, subcutaneous levodopa/carbidopa infusion with ND0612 in Parkinson's disease: 3-year outcomes from the open-label BeyoND study
Aaron L Ellenbogen, Werner Poewe, Alberto J Espay, et al.
Neurology and Therapy
|
June 15, 2022
Opicapone as an Add-on to Levodopa in Patients with Parkinson's Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON Trial
Joaquim J Ferreira, Werner Poewe, Olivier Rascol, et al.
Journal of Parkinson'S Disease
|
November 19, 2023
Apomorphine Sublingual Film Compared with Subcutaneous Apomorphine for OFF Episodes in Parkinson's Disease: An Open-Label, Randomized, Crossover Study
Fabrizio Stocchi, Olivier Rascol, Werner Poewe, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 2, 2022
Effect of Opicapone on Levodopa Pharmacokinetics in Patients with Fluctuating Parkinson's Disease
Joaquim J Ferreira, Werner Poewe, Olivier Rascol, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 25, 2017
Very late-onset pure autonomic failure
Alessandra Fanciulli, Nadia Stefanova, Christoph Scherfler, et al.
Page
of 61
Search research articles
Search
Showing results (331-340 of 602) with videos related to
Sort By:
Page
of 61
Parkinsonism & Related Disorders
|
December 22, 2019
Midbrain hyperechogenicity, hyposmia, mild parkinsonian signs and risk for incident Parkinson's disease over 10 years: A prospective population-based study
Philipp Mahlknecht, Heike Stockner, Kathrin Marini, et al.
Annals of Neurology
|
July 23, 2005
Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome
Christoph Schmidauer, Martin Sojer, Klaus Seppi, et al.
Pharmacoeconomics - Open
|
October 31, 2025
Cost-Effectiveness Modelling of Multiple System Atrophy for Early Health Technology Assessment
Tobias Sydendal Grand, Shijie Ren, Praveen Thokala, et al.
Neuro-Degenerative Diseases
|
May 22, 2013
Substantia nigra hyperechogenicity as a marker for Parkinson's disease: a population-based study
Philipp Mahlknecht, Klaus Seppi, Heike Stockner, et al.
Brain Sciences
|
May 28, 2022
Eye Tracking in Patients with Parkinson's Disease Treated with Nabilone-Results of a Phase II, Placebo-Controlled, Double-Blind, Parallel-Group Pilot Study
Philipp Ellmerer, Marina Peball, Federico Carbone, et al.
Parkinsonism & Related Disorders
|
January 30, 2025
Long-term, continuous, subcutaneous levodopa/carbidopa infusion with ND0612 in Parkinson's disease: 3-year outcomes from the open-label BeyoND study
Aaron L Ellenbogen, Werner Poewe, Alberto J Espay, et al.
Neurology and Therapy
|
June 15, 2022
Opicapone as an Add-on to Levodopa in Patients with Parkinson's Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON Trial
Joaquim J Ferreira, Werner Poewe, Olivier Rascol, et al.
Journal of Parkinson'S Disease
|
November 19, 2023
Apomorphine Sublingual Film Compared with Subcutaneous Apomorphine for OFF Episodes in Parkinson's Disease: An Open-Label, Randomized, Crossover Study
Fabrizio Stocchi, Olivier Rascol, Werner Poewe, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 2, 2022
Effect of Opicapone on Levodopa Pharmacokinetics in Patients with Fluctuating Parkinson's Disease
Joaquim J Ferreira, Werner Poewe, Olivier Rascol, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 25, 2017
Very late-onset pure autonomic failure
Alessandra Fanciulli, Nadia Stefanova, Christoph Scherfler, et al.
Page
of 61